AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.20 / 10
Netural
Money flow is robust (7.66/10) with positive small, medium, and large inflows, despite negative block and extra-large trends. Analyst consensus is neturally bullish with 40% Strong Buy and 60% Buy ratings, but historical win rates vary, indicating a need for cautious interpretation.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
40%
Buy
60%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-03
InstitutionJefferies
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for AXSM?
- AXSM holds a Bearish analyst rating, with 60% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.20/10 (Netural).
